Forbes Harriet J, Benjamin Laura, Breuer Judy, Brown Martin M, Langan Sinéad M, Minassian Caroline, Smeeth Liam, Thomas Sara L, Warren-Gash Charlotte
Faculty of Epidemiology & Population Health, London School of Hygiene and Tropical Medicine, London, UK.
Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
BMJ Open. 2017 May 29;7(5):e016427. doi: 10.1136/bmjopen-2017-016427.
After primary infection, human herpesviruses establish latency and persist lifelong. Periodic virus reactivation can lead to serious inflammatory complications. Recent research suggests that herpesvirus reactivation may also be linked to acute stroke. An improved understanding of this relationship is vital to inform public health prevention strategies. We will review the evidence regarding the role of human herpesviruses in triggering stroke.
A systematic literature review of published and grey literature studies with a human herpesvirus (infection or reactivation) as an exposure and stroke as an outcome will be carried out. Randomised controlled trials, cohort, case-control, case crossover and self-controlled case series designs will be eligible; no restrictions will be placed on publication status, language and geographical or healthcare setting. The Cochrane Central Register of Controlled Trials, Embase, Global Health, Medline, Scopus and Web of Science will be searched from dates of inception to January 2017. A prespecified search strategy of medical subject headings and free text terms (in the title and abstract) for human herpesviruses AND stroke will be used. Two reviewers will independently screen titles and abstracts for eligible studies, followed by full-text screening. The reviewers will then extract data from the eligible studies using standardised, pilot-tested tables and assess risk of bias in individual studies, in line with the Cochrane Collaboration approach. The data will be synthesised in a narrative format, and meta-analyses considered where there are sufficient data. Quality of evidence will be assessed in line with theGrading of Recommendations, Assessment, Development and Evaluation (GRADE) approach.
As this is a systematic review, ethical approval is not required. The results will be submitted for peer-review publication and presented at national conferences. A lay and short summary will be disseminated on appropriate webpages.
CRD42017054502.
初次感染后,人类疱疹病毒会进入潜伏状态并终生存在。病毒的周期性重新激活可导致严重的炎症并发症。最近的研究表明,疱疹病毒重新激活可能还与急性中风有关。更好地理解这种关系对于制定公共卫生预防策略至关重要。我们将综述关于人类疱疹病毒在引发中风中作用的证据。
将对已发表和灰色文献研究进行系统的文献综述,这些研究以人类疱疹病毒(感染或重新激活)为暴露因素,中风为结局。随机对照试验、队列研究、病例对照研究、病例交叉研究和自我对照病例系列设计均符合要求;对发表状态、语言以及地理或医疗环境不设限制。将检索Cochrane对照试验中心注册库、Embase、全球健康数据库、Medline、Scopus和科学网,检索时间从各数据库建库起至2017年1月。将使用针对人类疱疹病毒和中风的医学主题词及自由文本词(在标题和摘要中)的预先设定的检索策略。两名评审员将独立筛选标题和摘要以确定符合条件的研究,随后进行全文筛选。然后,评审员将使用标准化的、经过预试验的表格从符合条件的研究中提取数据,并根据Cochrane协作网的方法评估各个研究的偏倚风险。数据将以叙述形式进行综合,并在有足够数据时考虑进行荟萃分析。将根据推荐分级、评估、制定与评价(GRADE)方法评估证据质量。
由于这是一项系统综述,无需伦理批准。研究结果将提交同行评审发表,并在全国性会议上展示。将在适当的网页上发布一份通俗易懂的简短摘要。
PROSPERO注册号:CRD42017054502。